We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, announces today
FLIR Systems, Inc. (NASDAQ: FLIR) today announced modified thermal cameras for fast and safe non-contact elevated skin temperature* screening. The FLIR EST™ thermal screening solutions provide frontline screening
Surgical implant maker Xenco Medical has announced the nationwide launch of the first injection-molded titanium foam spinal implants pre-attached to disposable, composite polymer instruments, the CancelleX porous titanium
KDx Diagnostics, Inc., announced today that it has received Conformité Européene (CE) Marking for its innovative and proprietary urine-based test (the URO17™ test) for bladder cancer. CE marking
South Korea-based medical device company LivsMed has received the US Food and Drug Administration (FDA) 510(k) for its new ArtiSential Bipolar Maryland Dissectors. The company said that the
Switzerland-based medical technology firm MedAlliance has secured the CE Mark approval for its SELUTION SLR 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), to treat coronary arterial
Masimo (NASDAQ: MASI) today announced Bridge™, an opioid withdrawal solution that uses neuromodulation to aid in the reduction of symptoms associated with opioid withdrawal. Bridge, which has been
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced the
Global health technology firm Royal Philips has expanding its remote clinical collaboration and virtual training offerings across its portfolio, based on the Reacts collaborative platform. The Reacts platform
GenMark Diagnostics, a provider of molecular diagnostic testing systems, has launched its ePlex Respiratory Pathogen 2 (RP2) Panel in US, for commercial distribution and clinical use. The ePlex